These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8330765

  • 1. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia.
    Koh SC, Anandakumar C, Montan S, Ratnam SS.
    Gynecol Obstet Invest; 1993; 35(4):214-21. PubMed ID: 8330765
    [Abstract] [Full Text] [Related]

  • 2. Coagulation and fibrinolysis in preeclampsia and neonates.
    Tanjung MT, Siddik HD, Hariman H, Koh SC.
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):467-73. PubMed ID: 16244774
    [Abstract] [Full Text] [Related]

  • 3. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
    Nakashima A, Kobayashi T, Terao T.
    Gynecol Obstet Invest; 1996 Oct; 42(2):95-101. PubMed ID: 8878712
    [Abstract] [Full Text] [Related]

  • 4. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
    Philippé J, Offner F, Declerck PJ, Leroux-Roels G, Vogelaers D, Baele G, Collen D.
    Thromb Haemost; 1991 Mar 04; 65(3):291-5. PubMed ID: 1904655
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activators and their inhibitors in leukemic cell homogenates.
    Wada H, Kumeda Y, Ogasawara Z, Ohiwa M, Kaneko T, Tamaki S, Ohno T, Kageyama S, Kobayashi T, Deguchi K.
    Am J Hematol; 1993 Feb 04; 42(2):166-70. PubMed ID: 8438877
    [Abstract] [Full Text] [Related]

  • 6. Blood coagulation and fibrinolysis during normal pregnancy.
    van Wersch JW, Ubachs JM.
    Eur J Clin Chem Clin Biochem; 1991 Jan 04; 29(1):45-50. PubMed ID: 1904779
    [Abstract] [Full Text] [Related]

  • 7. Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia.
    Gilabert J, Estellés A, Aznar J, España F, Andrés C, Santos T, Vallés J.
    Thromb Haemost; 1990 Jun 28; 63(3):361-6. PubMed ID: 2144918
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
    Koh SC, Yuen R, Viegas OA, Chua SE, Ng BL, Sen DK, Ratnam SS.
    Thromb Haemost; 1991 Nov 01; 66(5):581-5. PubMed ID: 1803623
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
    Tran-Thang C, Fasel-Felley J, Pralong G, Hofstetter JR, Bachmann F, Kruithof EK.
    Thromb Haemost; 1989 Sep 29; 62(2):651-3. PubMed ID: 2510345
    [Abstract] [Full Text] [Related]

  • 10. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C, Proesmans W, Arnout J, Vermylen J, Declerck PJ.
    Kidney Int; 1998 Oct 29; 54(4):1324-30. PubMed ID: 9767551
    [Abstract] [Full Text] [Related]

  • 11. Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.
    Koh SC, Anandakumar C, Biswas A, Fong YF.
    Thromb Haemost; 2002 Jan 29; 87(1):175-6. PubMed ID: 11858184
    [No Abstract] [Full Text] [Related]

  • 12. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.
    van Hinsbergh VW, Bauer KA, Kooistra T, Kluft C, Dooijewaard G, Sherman ML, Nieuwenhuizen W.
    Blood; 1990 Dec 01; 76(11):2284-9. PubMed ID: 1701665
    [Abstract] [Full Text] [Related]

  • 13. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
    Prasad RN, Koh SC, Viegas OA, Ratnam SS.
    Clin Appl Thromb Hemost; 1999 Jan 01; 5(1):60-70. PubMed ID: 10725985
    [Abstract] [Full Text] [Related]

  • 14. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors.
    Kruithof EK, Tran-Thang C, Gudinchet A, Hauert J, Nicoloso G, Genton C, Welti H, Bachmann F.
    Blood; 1987 Feb 01; 69(2):460-6. PubMed ID: 2432970
    [Abstract] [Full Text] [Related]

  • 15. Haemostatic factors in women with history of preeclampsia.
    Portelinha A, Cerdeira AS, Belo L, Braga J, Tejera E, Pinto A, Pinto F, Areias MJ, Patrício B, Rebelo I.
    Thromb Res; 2009 May 01; 124(1):52-6. PubMed ID: 19049844
    [Abstract] [Full Text] [Related]

  • 16. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
    Mutoh S, Kobayashi M, Hirata J, Itoh N, Maki M, Komatsu Y, Yoshida A, Sasa H, Kuroda K, Kikuchi Y.
    Agents Actions Suppl; 1992 May 01; 38 ( Pt 2)():342-9. PubMed ID: 1462840
    [Abstract] [Full Text] [Related]

  • 17. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia.
    Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J.
    Br J Obstet Gynaecol; 1994 Jun 01; 101(6):488-92. PubMed ID: 8018635
    [Abstract] [Full Text] [Related]

  • 18. Clinical and haemostatic parameters in the HELLP syndrome: relevance of plasminogen activator inhibitors.
    Gilabert J, Estellés A, Ridocci F, España F, Aznar J, Galbis M.
    Gynecol Obstet Invest; 1990 Jun 01; 30(2):81-6. PubMed ID: 2147163
    [Abstract] [Full Text] [Related]

  • 19. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y.
    J Cardiol; 1993 Jun 01; 23(4):335-41. PubMed ID: 8064582
    [Abstract] [Full Text] [Related]

  • 20. Influence of delivery on plasminogen activator inhibitor activity.
    Koelbl H, Kirchheimer J, Tatra G.
    J Perinat Med; 1989 Jun 01; 17(2):107-11. PubMed ID: 2681664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.